Barcelona, Catalonia, Spain
I currently lead the launch of a new international laboratory in Spain, bringing an innovative approach to the pharmacy channel. Our work with ozonated extra virgin olive oil is opening the door to more effective, natural and science-backed treatments, particularly in the fields of oral and dermatological health. I oversee the strategic, commercial and operational rollout, building a business designed to make a real impact — and with clear ambitions for international expansion. In parallel, I’ve been actively involved for several years in the global growth of ThyroidPrint, a cutting-edge diagnostic test powered by AI and molecular medicine. It helps improve the accuracy of thyroid nodule diagnosis and is already supporting thousands of patients worldwide. Today, it’s present across four continents, setting a new benchmark in the clinical management of these cases. With over 20 years of experience, I’ve led strategic plans across healthcare, FMCG, cosmetics, insurance and banking, managing teams, launching products, building brands and negotiating international partnerships. I bring business vision, hands-on execution and cross-functional leadership. I’m also a proud cyber volunteer, contributing to digital training initiatives for vulnerable communities through Fundación Cibervoluntarios — a non-profit organisation that promotes technology as a driver for social change. If you believe in building purposeful businesses and turning bold ideas into solid ventures, I’d love to connect.
At GemaVip, we are pioneers in the research and development of personal care products based on ozone therapy. We specialize in innovative solutions that combine the benefits of ozone with other active ingredients, ensuring highly effective products for oral health and overall well-being. We work closely with industry professionals to offer products renowned for their bactericidal, antiviral, healing, and anti-inflammatory properties. Our commitment to science and technology allows us to continuously improve our formulas, ensuring the highest standards of quality and safety for our customers. With a global vision, we work tirelessly to transform personal care through innovation in ozone therapy.
Professor specializing in key areas of business and digital transformation: 1. Digital Project Management: Teaching students how to effectively plan, execute, and oversee digital projects from concept to completion, with a focus on tools, methodologies, and leadership in the digital era. 2. Strategic Decision Making: Guiding students through the process of making high-impact strategic decisions, using frameworks and real-world scenarios to evaluate risks, opportunities, and long-term outcomes. 3. Email Marketing and CRM: Covering the principles and best practices of email marketing campaigns, customer relationship management, and the integration of digital tools to foster engagement and drive business growth.
In today's dynamic business landscape, the customer experience is paramount to an organization's success. Each interaction holds significant value, and given the fierce competition we face, adeptly managing these experiences cultivates loyalty, sets businesses apart, and paves the way for sustained growth. From my position, I'm honored to delve deep into the core principles of this domain, mentoring dedicated professionals poised to make their mark in the business world.
At GeneproDx we aim to transform next-generation cancer diagnosis into a simple, fast, and seamless process for our patients. By using genomics and artificial intelligence our technology provide expedited and accurate information that improves patient outcomes and quality of life. Our platform provides a unique opportunity to develop novel tests that will answer meaningful clinical questions. Today, we are pioneers and leaders in the diagnosis of patients with indeterminate thyroid nodules in Europe & Latin America, through our molecular test ThyroidPrint. This allows us to avoid 75% of unnecessary surgeries, surgical risks, permanent hormone supplementation, and unnecessary health expenses. In a partnership will molecular diagnostics company Biocartis, ThyroidPrint will be the first of its kind globally available diagnostic kit. The cutting-edge diagnostic platform Idylla will allow us to provide a sample-to-insight result within the same day. Biocartis will provide manufacturing and distribution channels for ThyroidPrint leveraging its worldwide install base of more than 1.800 Idylla platforms. ThyroidPrint is: 95% Negative Predictive Value: Indicates that the probability of the nodule being malignant drops from 25% to less than 5% allowing follow-up to be recommended as an alternative to surgery. 78% Positive Predictive Value: Indicates that the probability that the nodule is malignant rises from 25% to 78%, therefore surgery is recommended. 88% Specificity: Indicates the percentage of benign cases that are correctly identified and will avoid unnecessary surgery.